TrialAnnals of the rheumatic diseases2007

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.

Daniel E Furst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.